Wedell-Wedellsborg Johan
Director at Y-mAbs Therapeutics, Inc.
- Sold, on record
- $19.4M
- Dollars the filings state
- Form 4 sales
- 10
- Latest Jun 10, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Y-mAbs Therapeutics, Inc.Director
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Y-mAbs Therapeutics, Inc.Plan not statedAug 28, 2019 2019
Sold 49,357 shares at $27.08 ($1.3M)
Wedell-Wedellsborg Johan, Director, 10% owner
Sold 7.5% of holdings ($17.7M position)604,801 shares leftFiling
- 2 Form 4 sale Y-mAbs Therapeutics, Inc.Plan not statedAug 30, 2019 +2 days
Sold 89,166 shares at $26.58 ($2.4M)
Wedell-Wedellsborg Johan, Director, 10% owner
Sold 14.7% of holdings ($16.1M position)515,635 shares left1.8x usual sizeFiling
- 3 Form 4 sale Y-mAbs Therapeutics, Inc.Plan not statedSep 6, 2019 +7 days
Sold 17,243 shares at $27.00 ($466k)
Wedell-Wedellsborg Johan, Director
Sold 3.3% of holdings ($13.9M position)498,392 shares left0.2x usual sizeFiling
- 4 Form 4 sale Y-mAbs Therapeutics, Inc.Plan not statedJun 1, 2021 +634 days
Sold 31,864 shares at $36.17 ($1.2M)
Wedell-Wedellsborg Johan, Director
Sold 0.7% of holdings ($162M position)4.4M shares left0.6x usual sizeFiling
- 5 Form 4 sale Y-mAbs Therapeutics, Inc.Plan not statedJun 4, 2021 +3 days
Sold 34,507 shares at $33.28 ($1.1M)
Wedell-Wedellsborg Johan, Director
Sold 0.8% of holdings ($148M position)4.4M shares left0.8x usual sizeFiling
- 6 Form 4 sale Y-mAbs Therapeutics, Inc.Plan not statedJun 7, 2021 +3 days
Sold 72,400 shares at $34.15 ($2.5M)
Wedell-Wedellsborg Johan, Director
Sold 1.6% of holdings ($151M position)4.3M shares left2.1x usual sizeFiling
- 7 Form 4 sale Y-mAbs Therapeutics, Inc.UnusualJun 9, 2021 +2 days
Sold 150,000 shares at $35.99 ($5.4M)
Wedell-Wedellsborg Johan, Director
Sold 3.5% of holdings ($156M position)4.2M shares left3.6x usual sizeFiling
- 8 Form 4 sale Y-mAbs Therapeutics, Inc.Plan not statedJun 10, 2021 +1 day
Sold 11,229 shares at $36.15 ($406k)
Wedell-Wedellsborg Johan, Director
Sold 0.3% of holdings ($151M position)4.2M shares left0.2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (10)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jun 10, 2021 | Jun 11, 2021 | Y-mAbs Therapeutics, Inc. | Director | Form 4 sale | 11,229 | $406k | 0.3% | Plan not stated | SEC |
| Jun 9, 2021 | Jun 10, 2021 | Y-mAbs Therapeutics, Inc. | Director | Form 4 sale | 150,000 | $5.4M | 3.5% | Unusual | SEC |
| Jun 7, 2021 | Jun 9, 2021 | Y-mAbs Therapeutics, Inc. | Director | Form 4 sale | 72,400 | $2.5M | 1.6% | Plan not stated | SEC |
| Jun 4, 2021 | Jun 7, 2021 | Y-mAbs Therapeutics, Inc. | Director | Form 4 sale | 34,507 | $1.1M | 0.8% | Plan not stated | SEC |
| Jun 1, 2021 | Jun 2, 2021 | Y-mAbs Therapeutics, Inc. | Director | Form 4 sale | 31,864 | $1.2M | 0.7% | Plan not stated | SEC |
| Sep 6, 2019 | Sep 9, 2019 | Y-mAbs Therapeutics, Inc. | Director | Form 4 sale | 17,243 | $466k | 3.3% | Plan not stated | SEC |
| Aug 30, 2019 | Sep 3, 2019 | Y-mAbs Therapeutics, Inc. | Director, 10% owner | Form 4 sale | 89,166 | $2.4M | 14.7% | Plan not stated | SEC |
| Aug 28, 2019 | Aug 29, 2019 | Y-mAbs Therapeutics, Inc. | Director, 10% owner | Form 4 sale | 49,357 | $1.3M | 7.5% | Plan not stated | SEC |
| Aug 22, 2019 | Aug 26, 2019 | Y-mAbs Therapeutics, Inc. | Director, 10% owner | Form 4 sale | 990 | $27k | 0.2% | Plan not stated | SEC |
| Aug 21, 2019 | Aug 22, 2019 | Y-mAbs Therapeutics, Inc. | Director, 10% owner | Form 4 sale | 168,244 | $4.6M | 20.2% | Plan not stated | SEC |